Growth Stocks

Market Insights - Growth Stocks

"Growth" stocks are equities issued by companies expected to grow at an above-average rate compared to the overall market. These stocks typically exhibit strong revenue and earnings growth potential, often reinvesting profits into expanding operations, developing new products, or entering new markets. Key characteristics of growth stocks include high price-to-earnings (P/E) ratios, as investors are willing to pay a premium for the anticipated growth. These stocks may not pay dividends as they prioritize reinvestment for expansion.

Ticker Security Name ⇅ PrevClose Beta MarketCap PE Ratio ⇅ Dividend Yield PBV Ratio ⇅ Category
ANANTRAJ Anant Raj Ltd. 540.35 1.016 16771.467 41.322 0.002 4.211 Mid-Cap
CGCL Capri Global Capital Ltd. 187.67 0.306 13125.966 33.256 0.001 3.143 Mid-Cap
ASTRAZEN Astrazeneca Pharma India Ltd. 9203.0 0.434 19188.844 191.205 0.003 27.144 Mid-Cap
CHOICEIN Choice International Ltd. 780.7 0.376 9596.442 62.893 0.0 10.351 Mid-Cap
KRN KRN Heat Exchanger And Refrigeration Ltd. 777.15 0.0 5774.35 141.443 0.0 11.091 Mid-Cap
CCL CCL Products (India) Ltd. 976.8 0.609 7616.44 26.774 0.008 4.033 Mid-Cap
ASTRAMICRO Astra Microwave Products Ltd. 885.9 1.073 5916.031 42.517 0.003 5.797 Mid-Cap
AURIONPRO Aurionpro Solutions Ltd. 1079.8 0.775 7208.391 38.373 0.001 4.928 Mid-Cap
CENTURYPLY Century Plyboards (India) Ltd. 798.95 0.969 15684.282 71.174 0.001 6.679 Mid-Cap
CAPLIPOINT Caplin Point Laboratories Ltd. 1976.1 0.752 14000.958 26.302 0.003 5.291 Mid-Cap
No data found for this filter.

Select a filter to view information.

Top 10 Stocks to Buy on

About Anant Raj Ltd. and Its Industry:

Anant Raj Ltd. is a prominent player in the real estate sector, specializing in developing commercial, residential, and retail properties. The company has a strong foothold in various regions, offering innovative and sustainable construction solutions to meet the evolving needs of its customers. With a focus on quality construction and timely project delivery, Anant Raj Ltd. has built a reputation for excellence in the industry over the years. Despite its established position in the real estate market, Anant Raj Ltd. faces challenges related to regulatory changes, market volatility, and intense competition. These factors can impact the company's growth trajectory and profitability.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹540.35
    • Market Cap: ₹16771.467
    • Category: Mid-Cap
    • Beta: 1.016
  • P/E Ratio: 41.322
  • Dividend Yield: 0.002%
  • Price-to-Book Value (PBV): 4.211

About Capri Global Capital Ltd. and Its Industry:

Capri Global Capital Ltd. is a diversified financial services company that focuses on providing customized financial solutions to individuals, businesses, and institutions. With a strong presence in the lending, investment advisory, and wealth management sectors, Capri Global Capital Ltd. plays a vital role in facilitating access to credit and financial expertise for its clients in India and beyond. The company leverages its expertise in risk assessment and financial planning to tailor solutions that meet the unique needs of its diverse customer base, establishing itself as a trusted partner in the financial services landscape. Challenges and opportunities lie ahead for Capri Global Capital Ltd. Challenges may include navigating changing regulatory environments, managing risks associated with lending operations, and ensuring sustainable growth amidst market volatility.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹187.67
    • Market Cap: ₹13125.966
    • Category: Mid-Cap
    • Beta: 0.306
  • P/E Ratio: 33.256
  • Dividend Yield: 0.001%
  • Price-to-Book Value (PBV): 3.143

About Astrazeneca Pharma India Ltd. and Its Industry:

AstraZeneca Pharma India Ltd. is a leading pharmaceutical company operating in the Indian market. The company focuses on developing, manufacturing, and marketing a wide range of pharmaceutical products, including prescription drugs for various therapeutic areas. With a strong presence in the Indian pharmaceutical industry, AstraZeneca Pharma India Ltd. plays a vital role in providing innovative healthcare solutions to patients across the country. The company's commitment to research and development, coupled with its reputation for quality products, has positioned it as a trusted player in the industry. Challenges and opportunities lie ahead for AstraZeneca Pharma India Ltd. in the competitive pharmaceutical landscape. The company faces challenges such as increasing regulatory scrutiny, evolving market dynamics, and the need to maintain competitive pricing strategies.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹9203.0
    • Market Cap: ₹19188.844
    • Category: Mid-Cap
    • Beta: 0.434
  • P/E Ratio: 191.205
  • Dividend Yield: 0.003%
  • Price-to-Book Value (PBV): 27.144

About Choice International Ltd. and Its Industry:

Choice International Ltd. is a global financial services company that specializes in providing a wide range of investment and advisory services to clients worldwide. With a strong presence in key financial markets, the company offers services ranging from wealth management and asset management to investment banking and corporate advisory. Known for its expertise in navigating complex financial landscapes and delivering tailored solutions, Choice International Ltd. plays a crucial role in shaping the financial strategies of individuals and institutions, helping them achieve their financial goals effectively. However, Choice International Ltd. faces challenges in an increasingly competitive industry where regulatory changes and technological advancements continuously impact the way financial services are delivered. Adapting to these changes while maintaining high standards of client service and compliance presents a significant challenge.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹780.7
    • Market Cap: ₹9596.442
    • Category: Mid-Cap
    • Beta: 0.376
  • P/E Ratio: 62.893
  • Dividend Yield: 0.0%
  • Price-to-Book Value (PBV): 10.351

About KRN Heat Exchanger And Refrigeration Ltd. and Its Industry:

KRN Heat Exchanger And Refrigeration Ltd. is a specialized company in the manufacturing and distribution of heat exchangers and refrigeration equipment. With a focus on providing high-quality, efficient products, KRN has established a strong reputation in the industry for its innovative solutions and reliable customer service. The company plays a vital role in supporting various sectors such as HVAC, industrial processes, and refrigeration systems, helping clients optimize their energy usage and operational efficiency. Challenges and opportunities lie ahead for KRN as it navigates through a competitive market and evolving technologies. One of the key challenges facing the company is staying ahead in the rapidly changing industry landscape, where advancements in energy efficiency and sustainability drive customer preferences.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹777.15
    • Market Cap: ₹5774.35
    • Category: Mid-Cap
    • Beta: 0.0
  • P/E Ratio: 141.443
  • Dividend Yield: 0.0%
  • Price-to-Book Value (PBV): 11.091

About CCL Products (India) Ltd. and Its Industry:

CCL Products (India) Ltd. is a prominent player in the Indian coffee industry, specializing in the manufacturing and exporting of instant coffee. With a strong presence in over 90 countries, the company has established a reputation for quality and reliability. Leveraging state-of-the-art facilities and cutting-edge technology, CCL Products has positioned itself as a key supplier in the global coffee market, catering to both retail and industrial customers. In a competitive industry with changing consumer preferences and global economic fluctuations, CCL Products faces challenges such as ensuring cost-efficiency in production, maintaining consistent quality standards, and navigating volatile market conditions.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹976.8
    • Market Cap: ₹7616.44
    • Category: Mid-Cap
    • Beta: 0.609
  • P/E Ratio: 26.774
  • Dividend Yield: 0.008%
  • Price-to-Book Value (PBV): 4.033

About Astra Microwave Products Ltd. and Its Industry:

Astra Microwave Products Ltd. is a leading Indian company that specializes in designing, developing, and manufacturing RF and microwave systems for defense, space, telecommunications, and broadcasting sectors. The company has established a strong reputation for delivering high-quality and innovative solutions in the field of advanced electronics, catering to the evolving needs of its diversified customer base. Astra Microwave Products Ltd. plays a crucial role in providing cutting-edge technology solutions that empower various industries to enhance their communication, defense, and broadcasting capabilities. Challenges facing Astra Microwave Products Ltd. include intense competition in the industry stemming from the rapid technological advancements and evolving customer demands.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹885.9
    • Market Cap: ₹5916.031
    • Category: Mid-Cap
    • Beta: 1.073
  • P/E Ratio: 42.517
  • Dividend Yield: 0.003%
  • Price-to-Book Value (PBV): 5.797

About Aurionpro Solutions Ltd. and Its Industry:

Aurionpro Solutions Ltd. is a global technology solutions provider that focuses on delivering innovative solutions to clients across various industries. With expertise in areas such as digital innovation, cybersecurity, and banking technology, Aurionpro plays a vital role in helping organizations transform digitally and optimize their operations. The company leverages its deep industry knowledge and cutting-edge technologies to provide customized solutions that address the unique challenges faced by its clients, positioning itself as a trusted partner in driving business growth and efficiency. Challenges facing Aurionpro include navigating rapid technological advancements, which require continuous innovation and adaptation to stay relevant in a competitive landscape. The company also faces the challenge of meeting evolving client demands and expectations in an increasingly digital world.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹1079.8
    • Market Cap: ₹7208.391
    • Category: Mid-Cap
    • Beta: 0.775
  • P/E Ratio: 38.373
  • Dividend Yield: 0.001%
  • Price-to-Book Value (PBV): 4.928

About Century Plyboards (India) Ltd. and Its Industry:

Century Plyboards (India) Ltd. is a leading player in the Indian plywood and laminate industry. The company specializes in manufacturing plywood, laminates, and other related products for both residential and commercial use. With a strong presence in the market, Century Plyboards is known for its quality products and innovative designs that cater to a wide range of customer needs. The company has built a reputation for reliability and durability, making it a preferred choice for many consumers and businesses in India. Challenges and opportunities lie ahead for Century Plyboards within its industry. The company faces stiff competition from both domestic and international players, requiring continuous innovation and strategic market positioning to maintain its market share.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹798.95
    • Market Cap: ₹15684.282
    • Category: Mid-Cap
    • Beta: 0.969
  • P/E Ratio: 71.174
  • Dividend Yield: 0.001%
  • Price-to-Book Value (PBV): 6.679

About Caplin Point Laboratories Ltd. and Its Industry:

Caplin Point Laboratories Ltd. is a pharmaceutical company headquartered in Chennai, India, known for its focus on providing affordable and high-quality generic pharmaceutical products. With a strong presence in over 60 countries, Caplin Point specializes in the development, manufacturing, and marketing of a diverse range of pharmaceutical formulations, including oral solids, liquids, and ointments. The company has a track record of adhering to stringent quality standards and regulatory requirements, which has earned it a reputation for reliability and consistency in the industry. However, Caplin Point Laboratories faces challenges in a competitive market where regulatory changes can impact its operations and profitability. Adapting to evolving regulations while maintaining its commitment to quality poses a significant challenge for the company.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹1976.1
    • Market Cap: ₹14000.958
    • Category: Mid-Cap
    • Beta: 0.752
  • P/E Ratio: 26.302
  • Dividend Yield: 0.003%
  • Price-to-Book Value (PBV): 5.291